Literature DB >> 1979357

Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism.

A M Bolos1, M Dean, S Lucas-Derse, M Ramsburg, G L Brown, D Goldman.   

Abstract

Using the dopamine D2 receptor clone lambda hD2G1, Blum et al recently found that the D2/Taq I allele (A1) was present in 69% of 35 deceased alcoholics but in only 20% of an equal number of controls. To assess this association further, we evaluated the D2/Taq I polymorphism and a single-strand conformation polymorphism detected by polymerase chain reaction and nondenaturing gel electrophoresis (PCR-SSCP) of the 3' noncoding region of the D2 receptor gene. We studied 40 unrelated white alcoholics, 127 racially matched controls, and two white pedigrees. The Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-L) clinical diagnostic interviews were rated blindly by two clinicians. The SADS-L interviews and other data were then used to ascertain diagnoses according to the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) criteria. Alcoholics were subtyped according to age of onset, severity, presence of antisocial personality, and family history. No significant differences in either D2/Taq I or PCR-SSCP allele frequencies were observed between alcoholics, subpopulations of alcoholics, or controls. The PCR-SSCP polymorphism provided independent information against linkage at the D2 receptor locus. Several recombinants between the D2/Taq I locus and alcoholism were observed in two white families with an alcoholic parent who possessed the A1 allele. This study does not support a widespread or consistent association between the D2 receptor gene and alcoholism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979357

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  35 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

2.  Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP.

Authors:  G Sarkar; H S Yoon; S S Sommer
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

Review 4.  Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules.

Authors:  Taylor Wingo; Tanseli Nesil; Jung-Seok Choi; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2015-10-19       Impact factor: 4.147

Review 5.  PCR-SSCP: a method for the molecular analysis of genetic diseases.

Authors:  V Konstantinos Kakavas; Kakavas V Konstantinos; Panagiotis Plageras; Plageras Panagiotis; T Antonios Vlachos; Vlachos T Antonios; Agelos Papaioannou; Papaioannou Agelos; V Argiris Noulas; Noulas V Argiris
Journal:  Mol Biotechnol       Date:  2007-10-13       Impact factor: 2.695

6.  A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence.

Authors:  Fan Wang; Arthur Simen; Albert Arias; Qun-Wei Lu; Huiping Zhang
Journal:  Hum Genet       Date:  2012-12-01       Impact factor: 4.132

7.  Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence.

Authors:  San-Yuan Huang; Wei-Wen Lin; Fang-Jung Wan; Ai-Ju Chang; Huei-Chen Ko; Tso-Jen Wang; Pei-Lin Wu; Ru-Band Lu
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

8.  Linkage analysis versus association analysis: distinguishing between two models that explain disease-marker associations.

Authors:  S E Hodge
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

Review 9.  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors:  Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal:  Postgrad Med       Date:  2009-11       Impact factor: 3.840

10.  The Human Genome Project and eugenic concerns.

Authors:  K L Garver; B Garver
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.